InvestSMART

Raptor Metals Ltd (ASX: RAP) - Announcements

- Current share price for RAP : $0.030

ASX company news and announcements for Raptor Metals Ltd (RAP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Raptor Metals Ltd (RAP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Raptor Metals Ltd (RAP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Raptor Metals Ltd (RAP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$12 Medgate enters licence agreement with ResApp Health 4 Aug 2021 9:56AM $0.040 $0.030 fallen by 25%
$12 Trading Halt 2 Aug 2021 9:20AM $0.040 $0.030 fallen by 25%
$12 Quarterly Activities Report and Appendix 4C 30 Jul 2021 8:23AM $0.041 $0.030 fallen by 26.83%
$12 Quarterly Results and Investor Conference Call Notification 28 Jul 2021 9:05AM $0.042 $0.030 fallen by 28.57%
$12 Commercial agreement with Doctors on Demand in Australia 5 Jul 2021 9:21AM $0.045 $0.030 fallen by 33.33%
$12 ResApp study data published in peer-reviewed journal 5 Jul 2021 8:34AM $0.045 $0.030 fallen by 33.33%
$12 Notification of cessation of securities - RAP 2 Jul 2021 6:25PM $0.045 $0.030 fallen by 33.33%
$12 ResApp to present at the Gold Coast Investment Showcase 23 Jun 2021 8:42AM $0.045 $0.030 fallen by 33.33%
$12 Medgate extends European ResAppDx trial 3 Jun 2021 8:40AM $0.054 $0.030 fallen by 44.44%
$12 Corporate Overview Presentation 20 May 2021 8:49AM $0.055 $0.030 fallen by 45.45%
$12 Initial Director's Interest Notice 18 May 2021 9:40AM $0.051 $0.030 fallen by 41.18%
$12 Brian Leedman Reappointed as Executive Director 18 May 2021 9:33AM $0.051 $0.030 fallen by 41.18%
$12 First participant recruited in COVID-19 cough study 17 May 2021 9:03AM $0.047 $0.030 fallen by 36.17%
$12 Agreement with Ilara Health to sell ResAppDx in Kenya 4 May 2021 8:26AM $0.051 $0.030 fallen by 41.18%
$12 Quarterly Activities Report and Appendix 4C 30 Apr 2021 8:26AM $0.056 $0.030 fallen by 46.43%
$12 Quarterly Results and Investor Conference Call Notification 29 Apr 2021 8:45AM $0.056 $0.030 fallen by 46.43%
$12 Change in substantial holding 21 Apr 2021 6:51PM $0.055 $0.030 fallen by 45.45%
$12 Ceasing to be a substantial holder 20 Apr 2021 5:03PM $0.053 $0.030 fallen by 43.40%
$12 Appendix 3G 19 Apr 2021 4:36PM $0.056 $0.030 fallen by 46.43%
$12 Section 708A Notice and Appendix 2A 19 Apr 2021 8:56AM $0.059 $0.030 fallen by 49.15%
$12 Proposed issue of Securities - RAP 12 Apr 2021 9:18AM $0.068 $0.030 fallen by 55.88%
$12 ResApp secures firm commitments to raise $5.5 million 12 Apr 2021 8:58AM $0.068 $0.030 fallen by 55.88%
$12 Trading Halt 8 Apr 2021 9:18AM $0.068 $0.030 fallen by 55.88%
$12 Appendix 3G 1 Apr 2021 6:03PM $0.067 $0.030 fallen by 55.22%
$12 TGA clearance achieved for wearable 25 Mar 2021 9:28AM $0.070 $0.030 fallen by 57.14%

151 - 175 of 570 results

Page 7 of 23

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.